Downing Ventures Participates in $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Downing Ventures is delighted to announce its participation in the Series C funding round in Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives. Downing Ventures were existing investors in the round which was co-led by Tencent and Legal & General and new investors Xeraya, Puhua and IDO. Additional existing investors included investors Parkwalk and Cambridge Innovation Capital. The global nature of this important financing round brings new strategic and geographic capabilities that will further advance Congenica’s existing global footprint.

Click here to read the full article.

GET IN TOUCH!


  MAIL US
enquiries@growthinvest.com

  CALL US
020 7071 3945

FOLLOW US ON


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.